Literature DB >> 454899

The involvement of dopamine in the central actions of bupropion, a new antidepressant [proceedings].

H Canning, D Goff, M J Leach, A A Miller, J E Tateson, P L Wheatley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 454899      PMCID： PMC2043827     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  7 in total

1.  THE DISTRIBUTION OF DOPAMINE AND DOPA IN VARIOUS ANIMALS AND A METHOD FOR THEIR DETERMINATION IN DIVERSE BIOLOGICAL MATERIAL.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1964-09       Impact factor: 4.030

2.  Improved technique for the fluorimetric estimation of catecholamines.

Authors:  U von EULER; F LISHAJKO
Journal:  Acta Physiol Scand       Date:  1961-04

3.  Comparative studies on the effects of metoclopramide and some known neuroleptics on the EEG of the conscious rat [proceedings].

Authors:  M G Baxter; A A Miller; P L Wheatley
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

4.  Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.

Authors:  F E Soroko; N B Mehta; R A Maxwell; R M Ferris; D H Schroeder
Journal:  J Pharm Pharmacol       Date:  1977-12       Impact factor: 3.765

5.  Estimation of dopamine, noradrenaline, adrenaline and hydroxytryptamine from single rat brains.

Authors:  G Brownlee; T L Spriggs
Journal:  J Pharm Pharmacol       Date:  1965-07       Impact factor: 3.765

6.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

7.  Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.

Authors:  I Goodlet; S E Mireylees; M F Sugrue
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739
  7 in total
  5 in total

1.  The effect of bupropion on prolactin in a patient with a pituitary microadenoma.

Authors:  H H Harsch
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Bupropion fails to affect plasma prolactin and growth hormone in normal subjects.

Authors:  P D Whiteman; A W Peck; A S Fowle; P Smith
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

3.  Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism.

Authors:  R D Blitzer; R E Becker
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 4.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

Review 5.  Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse.

Authors:  Beatriz Correia; Joana Fernandes; Maria João Botica; Carla Ferreira; Alexandre Quintas
Journal:  Medicines (Basel)       Date:  2022-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.